Wall Street analysts forecast that Moderna Inc (NASDAQ) (NYSE:MRNA) will announce earnings of ($0.41) per share for the current quarter, according to Zacks. Three analysts have made estimates for Moderna Inc (NASDAQ)’s earnings, with the highest EPS estimate coming in at ($0.25) and the lowest estimate coming in at ($0.50). The firm is expected to announce its next earnings report on Thursday, August 8th.
Zacks’ EPS calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for Moderna Inc (NASDAQ).
Moderna Inc (NASDAQ) (NYSE:MRNA) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.35) by ($0.05). The firm had revenue of $16.03 million for the quarter, compared to the consensus estimate of $33.59 million.
Separately, Chardan Capital reissued a “buy” rating on shares of Moderna Inc (NASDAQ) in a report on Sunday, April 7th.
Shares of MRNA stock traded down $0.71 on Friday, hitting $20.78. The stock had a trading volume of 443,509 shares, compared to its average volume of 920,813. Moderna Inc has a twelve month low of $13.03 and a twelve month high of $29.79.
Moderna Inc (NASDAQ) Company Profile
Moderna, Inc, a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. As of February 15, 2019 the company had 11 programs in clinical trials and a total of 20 development candidates in six modalities comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics.
Recommended Story: What is the Beige Book?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Moderna Inc (NASDAQ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moderna Inc (NASDAQ) and related companies with MarketBeat.com's FREE daily email newsletter.